A detailed history of Financial Gravity Asset Management, Inc. transactions in Eli Lilly & CO stock. As of the latest transaction made, Financial Gravity Asset Management, Inc. holds 48 shares of LLY stock, worth $43,108. This represents 0.01% of its overall portfolio holdings.

Number of Shares
48
Previous 48 -0.0%
Holding current value
$43,108
Previous $28.2 Million 0.68%
% of portfolio
0.01%
Previous 0.01%

Shares

22 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 13, 2024

BUY
$592.2 - $792.28 $37,900 - $50,705
64 Added 1600.0%
68 $51.9 Million
Q4 2023

Jun 26, 2024

SELL
$525.19 - $619.13 $10,503 - $12,382
-20 Reduced 29.41%
48 $28.2 Million
Q3 2023

Nov 15, 2023

SELL
$434.7 - $599.3 $202,135 - $278,674
-465 Reduced 99.15%
4 $2,000
Q2 2023

Aug 08, 2023

BUY
$350.74 - $468.98 $44,193 - $59,091
126 Added 36.73%
469 $9.01 Million
Q1 2023

May 12, 2023

SELL
$310.63 - $364.82 $7,144 - $8,390
-23 Reduced 6.28%
343 $44,000
Q4 2022

Feb 15, 2023

SELL
$321.55 - $374.67 $401,615 - $467,962
-1,249 Reduced 77.34%
366 $8.21 Million
Q3 2022

Nov 03, 2022

SELL
$296.48 - $337.87 $1.73 Million - $1.97 Million
-5,837 Reduced 78.33%
1,615 $21,000
Q2 2022

Aug 05, 2022

BUY
$278.73 - $327.27 $1.68 Million - $1.97 Million
6,022 Added 421.12%
7,452 $2.49 Million
Q1 2022

May 13, 2022

SELL
$234.69 - $291.66 $1.28 Million - $1.6 Million
-5,470 Reduced 79.28%
1,430 $22,000
Q4 2021

Feb 11, 2022

BUY
$224.85 - $279.04 $1.55 Million - $1.93 Million
6,900 New
6,900 $3.44 Million
Q2 2021

Aug 11, 2021

SELL
$180.55 - $233.54 $2,708 - $3,503
-15 Closed
0 $0
Q1 2021

May 17, 2021

BUY
$164.32 - $212.72 $2,136 - $2,765
13 Added 650.0%
15 $2.84 Million
Q4 2020

Feb 16, 2021

BUY
$130.46 - $172.63 $260 - $345
2 New
2 $0
Q2 2020

Aug 13, 2020

SELL
$136.42 - $164.18 $15,688 - $18,880
-115 Closed
0 $0
Q1 2020

May 12, 2020

BUY
$119.05 - $147.35 $5,238 - $6,483
44 Added 61.97%
115 $15,000
Q4 2019

Feb 28, 2020

SELL
$106.92 - $132.43 $3,849 - $4,767
-36 Reduced 33.64%
71 $131,000
Q3 2019

Oct 15, 2019

BUY
$106.79 - $116.16 $5,553 - $6,040
52 Added 94.55%
107 $12,000
Q2 2019

Jul 26, 2019

SELL
$110.79 - $129.32 $43,540 - $50,822
-393 Reduced 87.72%
55 $6,000
Q1 2019

Apr 19, 2019

BUY
$111.31 - $131.02 $43,299 - $50,966
389 Added 659.32%
448 $58,000
Q3 2018

Oct 31, 2018

BUY
$85.86 - $107.31 $171 - $214
2 Added 3.51%
59 $6,000
Q2 2018

Aug 14, 2018

SELL
$75.7 - $86.88 $9,235 - $10,599
-122 Reduced 68.16%
57 $6,000
Q1 2018

May 23, 2018

BUY
$74.21 - $87.6 $13,283 - $15,680
179 New
179 $14,000

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $853B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Financial Gravity Asset Management, Inc. Portfolio

Follow Financial Gravity Asset Management, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Financial Gravity Asset Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Financial Gravity Asset Management, Inc. with notifications on news.